TFF Pharmaceuticals ROE 2024

TFF Pharmaceuticals Aktienanalyse

What does TFF Pharmaceuticals do?

TFF Pharmaceuticals Inc is a biopharmaceutical company founded in 2018 and based in Austin, Texas. The company specializes in the development of inhalable drugs based on Thin Film Freezing technology. The history of TFF Pharmaceuticals began with the merger of two companies, Peloton Therapeutics and Infini Exploration. As a result of this fusion, the present-day TFF Pharmaceuticals was created. Since then, the company has experienced rapid growth and has become a leading provider of innovative inhalable medications. TFF Pharmaceuticals' business model includes the development and marketing of inhalable drugs based on patented Thin Film Freezing technology. This technology enables the production of medications in the form of nanoparticles that can be easily inhaled into the respiratory system. As a result, the drugs can directly reach the affected area of the lungs and have an immediate effect. TFF Pharmaceuticals' portfolio includes various areas such as oncology, respiratory diseases, infectious diseases, and rare diseases. The company is currently developing a variety of products in these areas, which have a significant market demand and can improve patients' quality of life. One example of a TFF Pharmaceuticals product is the inhalable medication Voriconazole-TFF. It is an innovative formulation of Voriconazole, an antifungal used for fungal infections. Voriconazole-TFF achieves a higher concentration in lung tissue and thus has a higher effectiveness than conventional Voriconazole products. The medication has been approved by the U.S. Food and Drug Administration (FDA) and is already on the market. Another example is the inhalable medication Tacrolimus-TFF, which is being developed for the treatment of lung transplant rejections. The Thin Film Freezing technology enables the production of Tacrolimus in nanoparticles that can directly reach the lungs and activate immunosuppression specifically there. TFF Pharmaceuticals closely collaborates with various partners to successfully market its products. These include pharmaceutical companies that take over the marketing of the products in different countries, as well as research institutes and medical facilities that work with TFF Pharmaceuticals to further develop its technology and products. Overall, TFF Pharmaceuticals is an innovative company specialized in the development of inhalable medications. With its patented Thin Film Freezing technology, the company has quickly made a name for itself and successfully brought its products to the market. TFF Pharmaceuticals' products have the potential to improve the lives of millions of patients worldwide, and the company will continue to play an important role in the pharmaceutical industry. TFF Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding TFF Pharmaceuticals's Return on Equity (ROE)

TFF Pharmaceuticals's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing TFF Pharmaceuticals's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

TFF Pharmaceuticals's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in TFF Pharmaceuticals’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about TFF Pharmaceuticals Stock

What is the ROE (Return on Equity) of TFF Pharmaceuticals this year?

The ROE of TFF Pharmaceuticals this year is -2.22 undefined.

How has the Return on Equity (ROE) of TFF Pharmaceuticals developed compared to the previous year?

The ROE of TFF Pharmaceuticals has increased by 59.91% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of TFF Pharmaceuticals?

A high ROE indicates that TFF Pharmaceuticals generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of TFF Pharmaceuticals?

A low ROE can indicate that TFF Pharmaceuticals is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of TFF Pharmaceuticals affect the company?

A change in ROE (Return on Equity) of TFF Pharmaceuticals can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of TFF Pharmaceuticals?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of TFF Pharmaceuticals?

Some factors that can influence TFF Pharmaceuticals's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does TFF Pharmaceuticals pay?

Over the past 12 months, TFF Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, TFF Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of TFF Pharmaceuticals?

The current dividend yield of TFF Pharmaceuticals is .

When does TFF Pharmaceuticals pay dividends?

TFF Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of TFF Pharmaceuticals?

TFF Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of TFF Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is TFF Pharmaceuticals located?

TFF Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von TFF Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of TFF Pharmaceuticals from 6/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/21/2024.

When did TFF Pharmaceuticals pay the last dividend?

The last dividend was paid out on 6/21/2024.

What was the dividend of TFF Pharmaceuticals in the year 2023?

In the year 2023, TFF Pharmaceuticals distributed 0 USD as dividends.

In which currency does TFF Pharmaceuticals pay out the dividend?

The dividends of TFF Pharmaceuticals are distributed in USD.